Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Hamlet Pharma HAMLET Sep 25, 2020 23.35 +29.72   
 Handelsbanken A SHBA Sep 25, 2020 74.34 -0.24   
 Handelsbanken B SHBB Sep 25, 2020 87.40 +0.23   
 Handicare Group HANDI Sep 25, 2020 36.00 +0.28   
 Hansa Biopharma HNSA Sep 25, 2020 230.60 +1.77   
 HANZA Holding HANZA Sep 25, 2020 14.00 -1.75   
 Havila Shipping HAVIO Sep 25, 2020 3.10 0.00   
 Havsfrun Investment HAVS Sep 25, 2020 18.80 +3.01   
 Havsfrun Investment B HAVB Sep 25, 2020 18.80 +3.01   
 Havyard Group HYARDO Sep 25, 2020 1.88 0.00   
 Heba B HEBAB Sep 25, 2020 112.50 +0.90   
 Hedera Group HEGR Sep 25, 2020 4.26 +0.47   
 Heimstaden Pref HEIMPREF Sep 25, 2020 370.00 +0.27   
 Heliospectra HELIO Sep 25, 2020 3.90 +1.43   
 Hemcheck Sweden HEMC Sep 25, 2020 3.11 +2.30   
 Herantis Pharma HRNTS Sep 25, 2020 75.60 -2.33   
 Hexagon B HEXAB Sep 25, 2020 646.00 +1.29   
 Hexagon Composites HEXO Sep 25, 2020 47.90 0.00   
 Hexatronic Group HTRO Sep 25, 2020 61.10 +0.33   
 Hexpol B HPOLB Sep 25, 2020 77.95 -0.19   
 Hiddn Solutions HIDDNO Sep 25, 2020 2.20 0.00   
 Hifab B HIFAB Sep 25, 2020 2.38 -0.83   
 HiQ International HIQ Sep 25, 2020 71.80 0.00   
 HMS Networks HMS Sep 25, 2020 204.00 +1.24   
 Hofseth BioCare HBCO Sep 25, 2020 8.14 0.00   
 Hoist Finance HOFI Sep 25, 2020 30.30 -1.30   
 Holmen A HOLMA Sep 25, 2020 376.00 +1.08   
 Holmen B HOLMB Sep 25, 2020 327.60 +0.37   
 HomeMaid B HOMEB Sep 25, 2020 7.30 +0.83   
 Hoodin HOODIN Sep 25, 2020 4.00 -2.08   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK